Norges Bank
RPTX

Norges Bank’s Repare Therapeutics RPTX Stock Holding History

Norges Bank’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-186,800
Closed -$3.94M – 2223
2021
Q4 		$3.94M Buy
+186,800
New +$4.4M ﹤0.01% 1951
2021
Q1 		– Sell
-14,970
Closed -$513K – 2190
2020
Q4 		$513K Sell
14,970
-35,030
-70% -$1.05M ﹤0.01% 2079
2020
Q3 		$1.54M Hold
50,000
– – ﹤0.01% 1990
2020
Q2 		$1.55M Buy
+50,000
New +$1.61M ﹤0.01% 1985

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Norges Bank's RPTX Position: Q1 2022 in Review

Norges Bank sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 186,800 shares — an estimated $3.94M sold.

Norges Bank first reported a position in RPTX in Q2 2020 and held it in 4 quarters. The position peaked at $3.94M in Q4 2021. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Norges Bank reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Norges Bank sold 186,800 Repare Therapeutics shares in Q1 2022, an estimated $3.94M.
  • Norges Bank first reported a position in Repare Therapeutics in Q2 2020 and held it in 4 quarters.
  • Norges Bank's Repare Therapeutics position peaked at $3.94M in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Norges Bank's 13F filing for Q1 2022, filed 9 May 2022.